Clinical trial

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

NCT00872560

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention NovoFine® needle 6 mm Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention NovoFine® needle 8 mm Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1998-01-20

PhasePHASE3

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Delivery Systemsunresolved

Interventions

NovoFine® needle 6 mmDEVICE

NovoFine® needle 8 mmDEVICE

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00872560 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.